WP4010 - Liver steatosis adverse outcome pathway - Homo sapiens
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接:
https://www.ndexbio.org/viewer/networks/5772d52f-1439-11f0-9806-005056ae3c32
下载链接
链接失效反馈官方服务:
资源简介:
This liver steatosis AOP starts from the top with different molecular initiating events going down towards liver steatosis. The black nodes are Key Events and green nodes are molecular pathways.
Adverse outcome pathway liver steatosis; the accumulation of lipids in hepatocytes, caused either by over-nutrition, visceral obesity, metabolic syndrome, or environmental toxins. Liver steatosis can be divided into three main categories: alcoholic liver disease (ALD), non-alcoholic liver disease (NAFLD), and toxicant-associated liver disease (TAFLD).[Review on liver steatosis](https://pubmed.ncbi.nlm.nih.gov/28210688/).
创建时间:
2025-04-17



